Skip to content
value.today

Solid Biosciences Inc.: insider trading

254 trades by 33 directors, officers and 10% owners since 2018, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$2.7 M
28 sales by 7 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$25 K
1 sale

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$26.1 M-$2.5 M$0Dec 2023: bought $0 (0 trades), sold $83 K (5 trades)Dec 23Jan 2024: bought $23.9 M (2 trades), sold $39 K (3 trades)May 2024: bought $0 (0 trades), sold $5 K (1 trades)MayJun 2024: bought $8 K (1 trades), sold $0 (0 trades)Oct 2024: bought $0 (0 trades), sold $19 K (1 trades)OctDec 2024: bought $0 (0 trades), sold $132 K (4 trades)Jan 2025: bought $0 (0 trades), sold $21 K (3 trades)Jan 25Feb 2025: bought $26.1 M (3 trades), sold $122 K (7 trades)Mar 2025: bought $10 K (1 trades), sold $0 (0 trades)MarOct 2025: bought $0 (0 trades), sold $17 K (1 trades)Nov 2025: bought $0 (0 trades), sold $14 K (1 trades)NovDec 2025: bought $0 (0 trades), sold $117 K (4 trades)Jan 2026: bought $0 (0 trades), sold $37 K (3 trades)Jan 26Feb 2026: bought $0 (0 trades), sold $2.5 M (20 trades)Oct 2026: bought $0 (0 trades), sold $25 K (1 trades)Oct
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (33)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Solid Biosciences Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Gabriel BrooksChief Medical Officer97,241—$288 K
Ian F. SmithDirector141,585——
Alexander CumboPresident and CEO, Director235,405—$984 K
David T. HowtonChief Operating Officer105,077—$434 K
Ilan GanotDirector99,297—$69 K
Jessie HanrahanChief Regulatory Officer74,318—$297 K
Kevin TanCFO & Treasurer99,422—$330 K
Paul HerzichChief Technology Officer72,638—$274 K
Clare KahnDirector2,960——
BCLS SB Investco, LP10% owner———
Joseph EdelmanDirector, 10% owner———
Robert Atchinson10% owner———
Adam KoppelDirector, 10% owner———
Perceptive Xontogeny Venture Fund, LPDirector, 10% owner———
RA Capital Nexus Fund, L.P.Director, 10% owner———
Jennifer MarloweCSO6,998——
Carl Ashley MorrisChief Scientific Officer19,760——
Ra Capital Management, L.P.Director, 10% owner———
Schneider Joel Solomon ZevChief Operating Officer236,270——
RA Capital Healthcare Fund LPDirector, 10% owner———
Peter KolchinskyDirector, 10% owner———
Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy335,636——
Matthew Bennett ArnoldDirector3.93 M——
Rajeev M. ShahDirector, 10% owner———
Lynette HerschaChief Legal Officer160,859——
Martin I. FreedDirector53,763——
Perceptive Advisors LLCDirector, 10% owner———
Sukumar NagendranDirector34,258——
Juan Andrey ZarurDirector691,105——
Boxer Capital, LLC10% owner3.47 M——
Pedro Alvaro AmorrortuChief Operating Officer153,746——
Jorge Armando QuirozChief Medical Officer228,092——
Gilad David Hayeem10% owner1.95 M——

Trades#

Solid Biosciences Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Gabriel BrooksChief Medical OfficerSell10b5-1 plan-4,374$5.620$25 K97,241Form 4
filed Kevin TanCFO & TreasurerSell10b5-1 plan-5,404$5.820$31 K99,422Form 4
filed Gabriel BrooksChief Medical OfficerSell10b5-1 plan-0$5.820$089,466Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-4,134$5.820$24 K74,318Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-7,469$5.820$43 K105,077Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-3,616$5.820$21 K72,638Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-2,658$5.820$15 K27,474Form 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-16,644$5.820$97 K235,405Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-12,348$6.440$80 K70,327Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-18,894$6.440$122 K97,859Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-10,905$6.440$70 K69,067Form 4
filed Kevin TanCFO & TreasurerSell10b5-1 plan-14,783$6.440$95 K94,201Form 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-48,913$6.440$315 K222,018Form 4
filed Gabriel BrooksChief Medical OfficerSell10b5-1 plan-12,616$6.440$81 K84,092Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-7,205$6.440$46 K25,271Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-26,250$6.440$169 K79,972Form 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-80,258$6.440$517 K270,931Form 4
filed Gabriel BrooksChief Medical OfficerSell10b5-1 plan-28,335$6.440$182 K96,708Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-26,535$6.440$171 K82,675Form 4
filed Kevin TanCFO & TreasurerSell10b5-1 plan-26,837$6.440$173 K108,984Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-37,771$6.440$243 K116,753Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-191$6.590$1 K17,476Form 4
filed Kevin TanCFO & TreasurerSell10b5-1 plan-5,704$5.270$30 K46,100Form 4
filed Ilan GanotDirectorSellindirect-1,053$5.430$6 K17,278Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-4,483$5.110$23 K26,660Form 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-10,808$5.110$55 K81,388Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-2,701$5.110$14 K26,622Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-4,932$5.110$25 K32,908Form 4
filed Ilan GanotDirectorSell-3,278$4.120$14 K95,412Form 4
filed Gabriel BrooksChief Medical OfficerSell-2,895$5.960$17 K33,819Form 4
filed Clare KahnDirectorBuy+1,860$5.340$10 K2,960Form 4
filed Joseph EdelmanDirector, 10% ownerBuyindirect+5.00 M$4.030$20.1 M11.83 MForm 4
filed BCLS SB Investco, LP10% ownerBuyindirect+1.00 M$4.030$4.0 M5.03 MForm 4
filed Robert Atchinson10% ownerBuyindirect+252,545$7.560$1.9 M4.25 MForm 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-11,365$3.960$45 K60,717Form 4
filed Gabriel BrooksChief Medical OfficerSell10b5-1 plan-3,256$3.960$13 K22,812Form 4
filed Kevin TanCFO & TreasurerSell10b5-1 plan-3,164$3.960$13 K32,250Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-3,079$3.960$12 K19,281Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-1,711$3.960$7 K14,839Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-5,561$3.960$22 K24,789Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-2,688$3.960$11 K18,388Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-144$3.110$44811,689Form 4
filed Kevin TanCFO & TreasurerSell-4,073$3.890$16 K24,789Form 4
filed Ilan GanotDirectorSellindirect-1,056$4.310$5 K11,445Form 4
filed Alexander CumboPresident and CEO, DirectorSell-11,114$5.600$62 K38,484Form 4
filed Jessie HanrahanChief Regulatory OfficerSell-4,610$5.600$26 K14,235Form 4
filed David T. HowtonChief Operating OfficerSell-5,072$5.600$28 K15,663Form 4
filed Paul HerzichChief Technology OfficerSell-2,777$5.600$16 K12,182Form 4
filed Gabriel BrooksChief Medical OfficerSell-2,923$6.500$19 K10,979Form 4
filed Clare KahnDirectorBuy+1,100$7.670$8 K1,100Form 4
filed Ilan GanotDirectorSellindirect-462$10.33$5 K9,507Form 4
filed Ilan GanotDirectorSellindirect-139$7.990$1 K8,416Form 4
filed RA Capital Nexus Fund, L.P.Director, 10% ownerBuyindirect+904,160$5.530$5.0 M4.19 MForm 4
filed Perceptive Xontogeny Venture Fund, LPDirector, 10% ownerBuyindirect+3.41 M$5.530$18.9 M6.83 MForm 4
filed Kevin TanCFO & TreasurerSell-3,935$8.200$32 K9,308Form 4
filed Ilan GanotDirectorSellindirect-1,142$5.300$6 K8,167Form 4
filed Paul HerzichChief Technology OfficerSell10b5-1 plan-2,968$2.770$8 K4,270Form 4
filed Alexander CumboPresident and CEO, DirectorSell10b5-1 plan-11,757$2.770$33 K17,439Form 4
filed Jennifer MarloweCSOSell10b5-1 plan-4,890$2.770$14 K6,998Form 4
filed Jessie HanrahanChief Regulatory OfficerSell10b5-1 plan-4,879$2.780$14 K6,983Form 4
filed David T. HowtonChief Operating OfficerSell10b5-1 plan-5,367$2.780$15 K7,684Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-487$4.850$2 K4,153Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell10b5-1 plan-441$7.490$3 K19,760Form 4
filed Ilan GanotDirectorSell10b5-1 plan · indirect-141$7.490$1 K1,378Form 4
filed Ilan GanotDirectorSell10b5-1 plan-1,382$7.490$10 K84,591Form 4
filed Schneider Joel Solomon ZevChief Operating OfficerSell10b5-1 plan-15,232$1.100$17 K251,542Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell10b5-1 plan-11,269$1.100$12 K266,605Form 4
filed Schneider Joel Solomon ZevChief Operating OfficerSell10b5-1 plan-15,272$1.100$17 K236,270Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell10b5-1 plan-11,396$1.100$13 K255,209Form 4
filed Ilan GanotCEO & President, DirectorSell10b5-1 plan · indirect-463$1.120$5192,518Form 4
filed Joseph EdelmanDirector, 10% ownerBuyindirect+2.61 M$5.750$15.0 M13.41 MForm 4
filed Peter KolchinskyDirector, 10% ownerBuyindirect+2.21 M$5.750$12.7 M10.92 MForm 4
filed Schneider Joel Solomon ZevChief Operating OfficerSell10b5-1 plan-11,699$8.840$103 K280,473Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell10b5-1 plan-11,699$8.840—287,301Form 4
filed Schneider Joel Solomon ZevChief Operating OfficerSell10b5-1 plan-11,699$8.840$103 K268,774Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell10b5-1 plan-11,699$8.850$104 K275,602Form 4
filed Ilan GanotCEO & President, DirectorSellindirect-457$7.660$4 K3,026Form 4
filed Schneider Joel Solomon ZevChief Technology OfficerSell-3,443$6.140$21 K292,172Form 4
filed Ilan GanotCEO & President, DirectorSell-10,713$6.140$66 K1.20 MForm 4
filed Carl Ashley MorrisChief Scientific OfficerSell-3,459$6.140$21 K299,000Form 4
filed Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecySell-3,473$6.140$21 K335,636Form 4
filed Ilan GanotCEO & President, DirectorSellindirect-299$2.440$7303,483Form 4
filed Ilan GanotCEO & President, DirectorSell-11,124$2.420$27 K1.15 MForm 4
filed Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. SecySell-3,591$2.420$9 K327,609Form 4
filed Schneider Joel Solomon ZevChief Technology OfficerSell-4,041$2.420$10 K284,115Form 4
filed Lynette HerschaChief Legal OfficerSell-5,141$2.420$12 K160,859Form 4
filed Carl Ashley MorrisChief Scientific OfficerSell-3,591$2.420—290,959Form 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+2.82 M$4.650$13.1 M6.75 MForm 4
filed Juan Andrey ZarurDirectorSell10b5-1 plan · indirect-8,000$10.00$80 K10,189Form 4
filed Boxer Capital, LLC10% ownerSell-60,000$9.530$572 K3.47 MForm 4
filed Boxer Capital, LLC10% ownerSell-115,000$9.600$1.1 M3.53 MForm 4
filed Boxer Capital, LLC10% ownerSell-275,000$10.08$2.8 M3.65 MForm 4
filed Matthew Bennett ArnoldDirectorSell10b5-1 plan-1,700$31.60$54 K3.39 MForm 4
filed Matthew Bennett ArnoldDirectorSell10b5-1 plan-3,300$32.20$106 K3.39 MForm 4
filed Matthew Bennett ArnoldDirectorSell10b5-1 plan-5,000$30.08$150 K3.39 MForm 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan · amended-9,000$30.07$271 K153,746Form 4/A
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-9,000$30.07$271 K158,046Form 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan · amended-3,007$30.20$91 K168,739Form 4/A
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan · amended-5,693$31.44$179 K163,046Form 4/A
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan · amended-300$32.38$10 K162,746Form 4/A
filed Jorge Armando QuirozChief Medical OfficerSell10b5-1 plan-1,200$29.94$36 K267,042Form 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-3,007$30.20$91 K173,039Form 4
filed Jorge Armando QuirozChief Medical OfficerSell10b5-1 plan-6,154$30.21$186 K260,888Form 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-5,693$31.44$179 K167,346Form 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-300$32.38$10 K167,046Form 4
filed Jorge Armando QuirozChief Medical OfficerSell10b5-1 plan-31,426$31.41$987 K229,462Form 4
filed Jorge Armando QuirozChief Medical OfficerSell10b5-1 plan-1,370$32.24$44 K228,092Form 4
filed Jorge Armando QuirozChief Medical OfficerSell10b5-1 plan-100$34.90$3 K268,242Form 4
filed Juan Andrey ZarurDirectorSell10b5-1 plan-100$35.00$4 K691,105Form 4
filed Schneider Joel Solomon ZevSee RemarksSell10b5-1 plan · amended-13,448$30.68$413 K133,198Form 4/A
filed Schneider Joel Solomon ZevSee RemarksSell10b5-1 plan · amended-8,542$31.10$266 K124,656Form 4/A
filed Schneider Joel Solomon ZevSee RemarksSell10b5-1 plan-13,448$30.68$413 K132,958Form 4
filed Ilan GanotCEO & President, DirectorSell10b5-1 plan-30,900$30.70$949 K1.12 MForm 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-4,700$30.61$144 K176,046Form 4
filed Ilan GanotCEO & President, DirectorSell10b5-1 plan-19,100$31.06$593 K1.10 MForm 4
filed Schneider Joel Solomon ZevSee RemarksSell10b5-1 plan-8,542$31.10$266 K126,656Form 4
filed Pedro Alvaro AmorrortuChief Operating OfficerSell10b5-1 plan-4,300$31.08$134 K171,746Form 4
filed Adam KoppelDirectorBuyindirect+300,000$16.00$4.8 M1.99 MForm 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+1.00 M$16.00$16.0 M3.91 MForm 4
filed Rajeev M. ShahDirectorBuyindirect+1.00 M$16.00—2.69 MForm 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+20,000$27.33$547 K3.93 MForm 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice